Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

Addgene

pOPINO_NbH11-H4 Citations (1)

Originally described in: Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2.
Huo J, Le Bas A, Ruza RR, Duyvesteyn HME, Mikolajek H, Malinauskas T, Tan TK, Rijal P, Dumoux M, Ward PN, Ren J, Zhou D, Harrison PJ, Weckener M, Clare DK, Vogirala VK, Radecke J, Moynie L, Zhao Y, Gilbert-Jaramillo J, Knight ML, Tree JA, Buttigieg KR, Coombes N, Elmore MJ, Carroll MW, Carrique L, Shah PNM, James W, Townsend AR, Stuart DI, Owens RJ, Naismith JH Nat Struct Mol Biol. 2020 Jul 13. pii: 10.1038/s41594-020-0469-6. doi: 10.1038/s41594-020-0469-6.
PubMed Journal

Articles Citing pOPINO_NbH11-H4

Articles
Targeting SARS-CoV-2 infection through CAR-T-like bispecific T cell engagers incorporating ACE2. Dogan M, Kozhaya L, Placek L, Karabacak F, Yigit M, Unutmaz D. Clin Transl Immunology. 2022 Oct 21;11(10):e1421. doi: 10.1002/cti2.1421. eCollection 2022. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.